Visualizing Severity Of Alopecia Tool Scores In The Clinical Setting Using Patient Images From A Clinical Trial

The study used images from the BRAVE-AA1 clinical trial, which included 722 patients with severe alopecia areata (AA), to demonstrate the application of the Severity of Alopecia Tool (SALT) scores in a clinical setting. The images, showing a range of SALT scores (0-100), illustrated hair regrowth progression in patients treated with baricitinib over 52 weeks. This visual approach helps clinicians understand and apply SALT scores for assessing disease severity and monitoring treatment response, aiding in treatment decisions and identifying patients for systemic therapies. However, the study notes limitations such as inter-rater variability and the inability of photographs to capture changes in hair density or active shedding.